biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The bioasis puppet

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 21, 2023 8:02pm

56 Views

Post# 35598971

RE:The bioasis puppet

I would like to take a wee look at your "puppet" metaphor, TT.

Rathjen has never had my unconditional support. I wanted her gone in 2019. Hell, she wanted me gone but the shareholders prevented that.

So, if you're saying I'm DrDR's puppet, whaddaya think? Are the strings all broken? Have they come unraveled.

I'm quite sure that the puppetmaster has no control over the puppet. I think that even the puppetmaster would say that she has no control over the puppet.

And everybody knows it.

But it is helpful when you do call me her puppet.

It's all so obvious.

jd

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload